Outcome of debridement and retention in prosthetic joint infections by methicillin-resistant staphylococci, with special reference to rifampin and fusidic acid combination therapy

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 1, 2013, Pages 350-355

  Peel, T N ^a,b   Buising, K L ^a   Dowsey, M M ^a,b   Aboltins, C A ^a   Daffy, J R ^a   Stanley, P A ^a   Choong, P F M ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; BETA LACTAM ANTIBIOTIC; CIPROFLOXACIN; FUSIDIC ACID; PRISTINAMYCIN; RIFAMPICIN; VANCOMYCIN; WARFARIN;

ACHILLES TENDINITIS; ACUTE KIDNEY FAILURE; AGED; ANTIBIOTIC THERAPY; ARTHROPLASTY; ARTICLE; BACTERIUM ISOLATE; CLINICAL ARTICLE; COAGULASE NEGATIVE STAPHYLOCOCCUS; DEBRIDEMENT; DISEASE FREE SURVIVAL; DISEASE SEVERITY; DRUG WITHDRAWAL; FEMALE; HUMAN; INTESTINE FLORA; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS INFECTION; PATIENT CARE; PRIORITY JOURNAL; PROSTHESIS INFECTION; RASH; RECURRENT DISEASE; RETROSPECTIVE STUDY; STAPHYLOCOCCUS EPIDERMIDIS; STAPHYLOCOCCUS INFECTION; SURGICAL WOUND; TREATMENT DURATION; TREATMENT FAILURE; TREATMENT OUTCOME;

AGED; ANTI-BACTERIAL AGENTS; ARTHROPLASTY; DEBRIDEMENT; DISEASE-FREE SURVIVAL; DRUG THERAPY, COMBINATION; FEMALE; FUSIDIC ACID; HUMANS; JOINT PROSTHESIS; MALE; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; PROSTHESIS-RELATED INFECTIONS; RETROSPECTIVE STUDIES; RIFAMPIN; STAPHYLOCOCCAL INFECTIONS; TREATMENT FAILURE;

EID: 84872017969     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02061-12     Document Type: Article

References (24)

1. Zimmerli W, Trampuz A, Ochsner PE. 2004. Prosthetic-joint infections. N. Engl. J. Med. 351:1645-1654.
2. Bradbury T, Fehring TK, Taunton M, Hanssen A, Azzam K, Parvizi J, Odum SM. 2009. The fate of acute methicillin-resistant Staphylococcus aureus periprosthetic knee infections treated by open debridement and retention of components. J. Arthroplasty 24:101-104.
3. Ferry T, Uckay I, Vaudaux P, Francois P, Schrenzel J, Harbarth S, Laurent F, Bernard L, Vandenesch F, Etienne J, Hoffmeyer P, Lew D. 2010. Risk factors for treatment failure in orthopedic device-related methicillin-resistant Staphylococcus aureus infection. Eur. J. Clin. Microbiol. Infect. Dis. 29:171-180.
4. Leung F, Richards CJ, Garbuz DS, Masri BA, Duncan CP. 2011. Two-stage total hip arthroplasty: how often does it control methicillin-resistant infection? Clin. Orthop. Relat. Res. 469:1009-1015.
5. Kurd MF, Ghanem E, Steinbrecher J, Parvizi J. 2010. Two-stage exchange knee arthroplasty: does resistance of the infecting organism influence the outcome? Clin. Orthop. Relat. Res. 468:2060-2066.
6. Soriano A, García S, Bori G, Almela M, Gallart X, Macule F, Sierra J,Martínez JA, Suso S, Mensa J. 2006. Treatment of acute post-surgical infection of joint arthroplasty. Clin. Microbiol. Infect. 12:930-933.
7. Parvizi J, Azzam K, Ghanem E, Austin M, Rothman R. 2009. Periprosthetic infection due to resistant staphylococci: serious problems on the horizon. Clin. Orthop. Relat. Res. 467:1732-1739.
8. Salgado CD, Dash S, Cantey JR, Marculescu CE. 2007. Higher risk of failure of methicillin-resistant Staphylococcus aureus prosthetic joint infections. Clin. Orthop. Relat. Res. 461:48-53.
9. Aboltins CA, Dowsey MM, Buising KL, Peel TN, Daffy JR, Choong PF, Stanley PA. 2011. Gram-negative prosthetic joint infection treated with debridement, prosthesis retention and antibiotic regimens including a fluoroquinolone. Clin. Microbiol. Infect. 17:862-867.
10. Aboltins CA, Page MA, Buising KL, Jenney AWJ, Daffy JR, Choong PFM. 2007. Treatment of staphylococcal prosthetic joint infections with debridement, prosthesis retention and oral rifampicin and fusidic acid. Clin. Microbiol. Infect. 13:586-591.
11. Choong PF, Dowsey MM, Carr D, Daffy J, Stanley P. 2007. Risk factors associated with acute hip prosthetic joint infections and outcome of treatment with a rifampin based regimen. Acta Orthop. 78:755-765.
12. Trampuz A, Zimmerli W. 2008. Diagnosis and treatment of implant-associated septic arthritis and osteomyelitis. Curr. Infect. Dis. Rep. 10:394-403.
13. Marculescu CE, Berbari EF, Hanssen AD, Steckelberg JM, Harmsen SW, Mandrekar JN, Osmon DR. 2006. Outcome of prosthetic joint infections treated with debridement and retention of components. Clin. Infect. Dis. 42:471-478.
14. Mittal Y, Fehring TK, Hanssen A, Marculescu C, Odum SM, Osmon D. 2007. Two-stage reimplantation for periprosthetic knee infection involving resistant organisms. J. Bone Joint Surg. Am. 89:1227-1231.
15. Lim S-J, Park J-C, Moon Y-W, Park Y-S. 2009. Treatment of periprosthetic hip infection caused by resistant microorganisms using 2-stage reimplantation protocol. J. Arthroplasty 24:1264-1269.
16. Kilgus DJ, Howe DJ, Strang A. 2002. Results of periprosthetic hip and knee infections caused by resistant bacteria. Clin. Orthop. Relat. Res. 404:116-124.
17. Deirmengian C, Greenbaum J, Lotke PA, Booth RE, Lonner JH. 2003. Limited success with open debridement and retention of components in the treatment of acute Staphylococcus aureus infections after total knee arthroplasty. J. Arthroplasty 18:22-26.
18. Lora-Tamayo J, Murillo O, Iribarren JA, Soriano A, Sanchez-Somolinos M, Baraia-Etxaburu JM, Rico A, Palomino J, Rodriguez-Pardo D, Horcajada JP, Benito N, Bahamonde A, Granados A, Del Toro MD,Cobo J, Riera M, Ramos A, Jover-Saenz A, Ariza J. 31 August 2012. A large multicenter study of methicillin susceptible- and methicillin resis-tant- Staphylococcus aureus prosthetic joint infections managed with implant retention. Clin. Infect. Dis. [Epub ahead of print.] doi:10.1093/cid/cis746.
19. Drancourt M, Stein A, Argenson JN, Zannier A, Curvale G, Raoult D. 1993. Oral rifampin plus ofloxacin for treatment of Staphylococcus-infected orthopedic implants. Antimicrob. Agents Chemother. 37:1214-1218.
20. Zimmerli W, Widmer AF, Blatter M, Frei R, Ochsner PE. 1998. Role of rifampin for treatment of orthopedic implant-related staphylococcal infections: a randomized controlled trial. J. Am. Med. Assoc. 279:1537-1541.
21. Senneville E, Joulie D, Legout L, Valette M, Dezeque H, Beltrand E, Rosele B, D'Escrivan T, Loiez C, Caillaux M, Yazdanpanah Y, Maynou C, Migaud H. 2011. Outcome and predictors of treatment failure in total hip/knee prosthetic joint infections due to Staphylococcus aureus. Clin. Infect. Dis. 53:334-340.
22. Byren I, Bejon P, Atkins BL, Angus B, Masters S, McLardy-Smith P, Gundle R, Berendt A. 2009. One hundred and twelve infected arthroplasties treated with 'DAIR' (debridement, antibiotics and implant retention): antibiotic duration and outcome. J. Antimicrob. Chemother. 63:1264-1271.
23. Laffer RR, Graber P, Ochsner PE, Zimmerli W. 2006. Outcome of prosthetic knee-associated infection: evaluation of 40 consecutive episodes at a single centre. Clin. Microbiol. Infect. 12:433-439.
24. Saginur R, St Denis M, Ferris W, Aaron SD, Chan F, Lee C, Ramotar K. 2006. Multiple combination bactericidal testing of staphylococcal biofilms from implant-associated infections. Antimicrob. Agents Chemother. 50:55-61.